Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Cannabidiol

EU orphan designation number: EU/3/15/1520   
Active ingredient: Cannabidiol
Indication: Treatment of perinatal asphyxia
Sponsor: GW Pharma (International) B.V
Databankweg 26, Amersfoort, Utrecht, 3821 AL, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/07/2015 Orphan designation EMA/OD/042/15 (2015)5427 of 28/07/2015
3/04/2019 Transfer of orphan designation EMA/OD/0000004600 (2019)2674 of 1/04/2019